These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 859748)

  • 1. [Prognostic value of determination of the degree of PHA-stimulated blastic transformation of lymphocytes in Hodgkin's disease].
    Pluzańska A
    Pol Arch Med Wewn; 1977 Apr; 57(4):307-11. PubMed ID: 859748
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies of the proportions of T, B and O-lymphocytes and of the degree of blastic transformation following stimulation with PHA in patients with Hodgkin's disease].
    Pluzańska A
    Pol Arch Med Wewn; 1977 Apr; 57(4):297-305. PubMed ID: 300871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prolonged and repeated stimulation with PHA and lymphocyte blastic response in Hodgkin's disease].
    Ippoliti G; Marini G; Ascari E; Casirola G
    Haematologica; 1973; 58(7):437-42. PubMed ID: 4200981
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
    Pluzańska A
    Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
    [No Abstract]   [Full Text] [Related]  

  • 5. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM; Litwin J; Bigel P; Oberling F; Mayer S
    Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
    Pappas A; Pees H; Girmann G
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin's disease: response of lymphocytes to PHA.
    Sforza MB; De Somoza N; Morgenfeld CM
    Sangre (Barc); 1971; 16(3):300-4. PubMed ID: 5120513
    [No Abstract]   [Full Text] [Related]  

  • 8. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte transformation caused by PHA and PPD in patients with Hodgkin's disease and its correlation with clinical and hematological aspects].
    Tognella S; Mantovani G; Malloci A; Del Giacco GS; Manconi PE; Grifoni V
    Haematologica; 1972; 57(9):552-5. PubMed ID: 4199311
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary data on phytohemagglutinin-induced blastic transformation of lymph-node cells of patients with Hodgkin's disease].
    Tognella S; Mantovani G; Floris C; Del Giacco GS; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):386-9. PubMed ID: 5082521
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte function in patients with Hodgkin's disease.
    Rühl H; Vogt W; Rühl U
    G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
    Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
    Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease.
    Rühl H; Vogt W; Bochert G; Schmidt S; Schaoua H; Moelle R
    Clin Exp Immunol; 1974 Jul; 17(3):407-15. PubMed ID: 4468860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of phytohaemagglutinin to serum substances and inhibition of lymphocyte transformation in Hodgkin's disease.
    Amlot PL; Unger A
    Clin Exp Immunol; 1976 Dec; 26(3):520-7. PubMed ID: 1009684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte reactivity to phytohaemagglutinin and allogeneic lymphocytes in 32 untreated patients with Hodgkin's disease.
    Lang JM; Oberling F; Bigel P; Mayer S; Waitz R
    Biomedicine; 1974 Sep; 21(9):372-7. PubMed ID: 4281669
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of repeated and prolonged stimulation on the PHA-response of lymphocytes in Hodgkin's disease.
    Ippoliti G; Marini G; Ascari E; Casirola G
    Acta Haematol; 1974; 51(5):266-9. PubMed ID: 4209031
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed hypersensitivity and lymphocytic transformation in patients with Hodgkin's disease and granulomas.
    Pick AI; Duer D; Kessler H; Kenan Z; Weiss H; Topilski M
    Cancer; 1978 Jun; 41(6):2192-6. PubMed ID: 657087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of phytohemagglutinin on lymphocytes in Hodgkin's disease].
    Eggerth G; Kühböck J; Pokorny D
    Wien Z Inn Med; 1969; 50(7):314-9. PubMed ID: 5380683
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative studies of macrophages in blood cultures in Hodgkin's disease.
    Novone R; Palestro G; Resegotti L
    Acta Haematol; 1975; 53(1):25-9. PubMed ID: 807071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro development of macrophages from PHA-stimulated blood cultures in Hodgkin's disease and in chronic lymphocytic leukaemia (author's transl)].
    Navone R; Tosto M; Poggio E
    Tumori; 1976; 62(1):19-24. PubMed ID: 1014113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.